DKSH has signed an exclusive distribution agreement with Omya, a leading global producer of mineral-based solutions, for France and Spain.
Media release
Zurich, December 3, 2020 – DKSH's Business Unit Performance Materials has become the exclusive distribution partner for Swiss-based company Omya in France and Spain. As part of the agreement, DKSH will provide marketing and sales, distribution and logistics as well as customer management for Omya's portfolio of nutraceutical and pharmaceutical ingredients. This partnership is in line with DKSH's strategic direction of expanding the Business Unit's leading position in specialty chemicals and ingredients distribution.
According to the product, the brands based on calcium carbonate (Omyapure®, Calcipur®, Calcipur® DC) can be used as Active Pharmaceutical Ingredients (API) or as excipients. In the first case, the most common application is calcium supplementation in the treatment of diseases, such as osteoporosis, osteopenia and rickets. As an API, calcium carbonate is also used as antacid in oral, solid or liquid medicines. When used as excipient, calcium carbonate either acts as a diluent or as a pH stabilizer of acid sensitive drugs.
The products based on Functionalized Calcium Carbonate (FCC) include the brands Omyapharm®, Omyanutra® and Omyaforte™. Omyapharm® and Omyanutra® are used as excipients in the formulation of pharmaceutical and nutraceutical oral solid dosage forms, respectively. Thanks to their very unique properties, both products provide high performance in formulations, such as fast disintegration, excellent compactibility or act as carriers for transforming liquid APIs into high compactable powders. Omyaforte® is a premium highly bio-available source of elemental calcium suitable for the formulation of nutraceuticals (food supplements).
DKSH was entrusted to grow Omya's business thanks to its extensive distribution network, strong service capabilities, deep technical know-how and formulation expertise and its proven track record as a strategic partner in Europe.
“Omya is delighted to start a strong and reliable partnership with DKSH. With their proven experience in the pharmaceutical and nutraceutical industries, DKSH will be able to offer Omya's solutions with a holistic complementary range of services satisfying the customer's expectations. We believe this is essential for reaching the market in the best possible way and to grow together with our partner,” said Dr. Javier Camargo, Global Business Development Manager, Pharmaceuticals and Nutraceuticals, Omya.
Dr. Tanja Schaffer, Vice President Global Pharmaceutical Industry, DKSH, added: “We are very pleased to partner with Omya for the first time in France and Spain, two of our key markets in Europe. Omya's range of solutions are an excellent fit for our pharmaceutical and nutraceutical portfolio. We very much look forward to seeing a lot of growth opportunities with Omya going forward.”
For further information, please contact:
Omya International AG Julia Sumpf Marketing Manager, Consumer Goods Phone +41 79 534 22 27 julia.sumpf@omya.com |
About Omya
Omya is a leading global producer of mineral-based solutions and a worldwide distributor of specialty ingredients. In the Consumer Goods segment, Omya offers innovative solutions based on high purity natural minerals and complementary ingredients that comply with the most stringent regulatory and quality standards targeting the food, personal care, pharma, petcare, homecare and filtration markets.
Founded in 1884 in Switzerland, Omya has a global presence extending to more than 175 locations in over 50 countries with 9,000 employees. Committed to implementing the principles of sustainability at all company levels, Omya provides added value products and services from responsibly sourced materials to meet the essential needs of current and future generations. https://pharma-nutra.omya.com/
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. The Group helps companies to grow across the Business Units Healthcare, Consumer Goods, Performance Materials and Technology. The service portfolio covers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Publicly listed on the SIX Swiss Exchange, the Group operates in 36 markets with 33,350 specialists, generating net sales of CHF 11.6 billion in 2019. With its Swiss heritage, DKSH has been deeply rooted in Asia Pacific since 1865. The DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care and various industrial applications. With 46 innovation centers and regulatory support worldwide, we create cutting-edge formulations that comply with local regulations. With around 1,100 specialists, the Business Unit generated net sales of CHF 1.0 billion in 2019.